Related Experiment Video
Updated: Aug 20, 2026

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
New diagnostic modalities in the diagnosis of heart failure
Judith E Mitchell1, Sanjeev Palta
1Department of Internal Medicine, Division of Cardiology, State University of New York Health Science Center at Brooklyn, Brooklyn, NY 11203, USA. judith.mitchell@downstate.edu
Insights
Diagnosing heart failure (HF) is challenging, with initial diagnosis accuracy around 50%. New methods like impedance cardiography and B-type natriuretic peptide assays show promise for improving heart failure diagnosis and management.
Area of Science:
- Cardiology
- Diagnostic Medicine
Background:
- Heart failure (HF) is a growing cardiovascular disease with increasing prevalence, particularly in aging populations.
- Initial diagnosis of HF is often inaccurate, with studies indicating correct diagnosis in only 50% of cases, despite standard diagnostic tools.
- Symptoms of HF decompensation can be easily mistaken for other conditions, complicating diagnosis.
Purpose of the Study:
- To explore novel diagnostic modalities for improving heart failure diagnostic accuracy.
- To identify methods for early detection of heart failure decompensations.
- To assess the potential of new tests in guiding pharmacological treatment for heart failure.
Main Methods:
- Utilizing impedance cardiography as a diagnostic tool.
- Employing B-type natriuretic peptide (BNP) assays for diagnostic assessment.
- Evaluating the effectiveness of these methods in both inpatient and outpatient settings.
Main Results:
- Impedance cardiography and BNP assays show promise in enhancing the accuracy of heart failure diagnosis.
- These new modalities may assist in the early recognition and prediction of acute heart failure decompensations.
- Potential to guide pharmacological treatment decisions for heart failure patients.
Conclusions:
- New diagnostic tests, including impedance cardiography and BNP assays, offer significant potential to improve heart failure diagnosis.
- These methods can aid in identifying early decompensations and optimizing treatment strategies.
- Advancements in diagnostic accuracy are crucial given the increasing prevalence of heart failure.
Abstract:
Heart failure (HF) is the one cardiovascular disease that is increasing in prevalence in the United States. As the population continues to age, the incidence will certainly be amplified. However, some studies have shown that HF is correctly diagnosed initially in only 50% of affected patients. Despite the use of history, physical examination, echocardiogram, and chest x-ray, the percentage of correct initial diagnosis of HF is low. Recognizing the symptoms of HF decompensations is often problematic because other diagnoses can mimic them. There are two new diagnostic modalities that offer promise in improving HF diagnostic accuracy and identifying early HF decompensations. These diagnostic modalities include tests utilizing impedance cardiography and the B-type natriuretic peptide assay. They have the potential of increasing the accuracy of HF diagnosis and guide pharmacological treatment in the inpatient and outpatient settings. They may also assist in the recognition (or prediction) of acute HF decompensations.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure IV: Classification and Diagnostic Evaluation
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...
Heart Failure VI: Adjunct Therapies
Dysrhythmias V: Evaluating Dysrhythmias
Heart Failure V: Medical Management